357 related articles for article (PubMed ID: 28826308)
21. Applying a variable relative biological effectiveness (RBE) might affect the analysis of clinical trials comparing photon and proton therapy for prostate cancer.
Marteinsdottir M; Paganetti H
Phys Med Biol; 2019 Jun; 64(11):115027. PubMed ID: 31082810
[TBL] [Abstract][Full Text] [Related]
22. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
[TBL] [Abstract][Full Text] [Related]
23. The impact of proton LET/RBE modeling and robustness analysis on base-of-skull and pediatric craniopharyngioma proton plans relative to VMAT.
Gutierrez A; Rompokos V; Li K; Gillies C; D'Souza D; Solda F; Fersht N; Chang YC; Royle G; Amos RA; Underwood T
Acta Oncol; 2019 Dec; 58(12):1765-1774. PubMed ID: 31429359
[No Abstract] [Full Text] [Related]
24. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
Stützer K; Lin A; Kirk M; Lin L
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
[TBL] [Abstract][Full Text] [Related]
25. Clinical implementation in proton therapy of multi-field optimization by a hybrid method combining conventional PTV with robust optimization.
Tommasino F; Widesott L; Fracchiolla F; Lorentini S; Righetto R; Algranati C; Scifoni E; Dionisi F; Scartoni D; Amelio D; Cianchetti M; Schwarz M; Amichetti M; Farace P
Phys Med Biol; 2020 Feb; 65(4):045002. PubMed ID: 31851957
[TBL] [Abstract][Full Text] [Related]
26. Reformulated McNamara RBE-weighted beam orientation optimization for intensity modulated proton therapy.
Ramesh P; Lyu Q; Gu W; Ruan D; Sheng K
Med Phys; 2022 Apr; 49(4):2136-2149. PubMed ID: 35181892
[TBL] [Abstract][Full Text] [Related]
27. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
[TBL] [Abstract][Full Text] [Related]
28. Can particle beam therapy be improved using helium ions? - a planning study focusing on pediatric patients.
Knäusl B; Fuchs H; Dieckmann K; Georg D
Acta Oncol; 2016 Jun; 55(6):751-9. PubMed ID: 26750803
[TBL] [Abstract][Full Text] [Related]
29. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy.
Hahn C; Eulitz J; Peters N; Wohlfahrt P; Enghardt W; Richter C; Lühr A
Med Phys; 2020 Dec; 47(12):6151-6162. PubMed ID: 33118161
[TBL] [Abstract][Full Text] [Related]
30. Hyperfractionated intensity-modulated proton therapy for pharyngeal cancer with variable relative biological effectiveness: A simulation study.
Kasamatsu K; Matsuura T; Yasuda K; Miyazaki K; Takao S; Tamura M; Otsuka M; Uchinami Y; Aoyama H
Med Phys; 2022 Dec; 49(12):7815-7825. PubMed ID: 36300598
[TBL] [Abstract][Full Text] [Related]
31. Hydrogel rectum-prostate spacers mitigate the uncertainties in proton relative biological effectiveness associated with anterior-oblique beams.
Underwood TS; Voog JC; Moteabbed M; Tang S; Soffen E; Cahlon O; Lu HM; Zietman AL; Efstathiou JA; Paganetti H
Acta Oncol; 2017 Apr; 56(4):575-581. PubMed ID: 28075206
[TBL] [Abstract][Full Text] [Related]
32. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
[TBL] [Abstract][Full Text] [Related]
33. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
Giantsoudi D; Adams J; MacDonald SM; Paganetti H
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
[TBL] [Abstract][Full Text] [Related]
34. Implementation of spot scanning dose optimization and dose calculation for helium ions in Hyperion.
Fuchs H; Alber M; Schreiner T; Georg D
Med Phys; 2015 Sep; 42(9):5157-66. PubMed ID: 26328967
[TBL] [Abstract][Full Text] [Related]
35. Normal tissue sparing potential of scanned proton beams with and without respiratory gating for the treatment of internal mammary nodes in breast cancer radiotherapy.
Dasu A; Flejmer AM; Edvardsson A; Witt Nyström P
Phys Med; 2018 Aug; 52():81-85. PubMed ID: 30139613
[TBL] [Abstract][Full Text] [Related]
36. Disregarding RBE variation in treatment plan comparison may lead to bias in favor of proton plans.
Wedenberg M; Toma-Dasu I
Med Phys; 2014 Sep; 41(9):091706. PubMed ID: 25186381
[TBL] [Abstract][Full Text] [Related]
37. Impact of potentially variable RBE in liver proton therapy.
Chen Y; Grassberger C; Li J; Hong TS; Paganetti H
Phys Med Biol; 2018 Sep; 63(19):195001. PubMed ID: 30183674
[TBL] [Abstract][Full Text] [Related]
38. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.
Henry T; Ödén J
Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384
[TBL] [Abstract][Full Text] [Related]
39. Dose averaged linear energy transfer optimization for large sacral chordomas in carbon ion therapy.
Schafasand M; Resch AF; Nachankar A; Góra J; Martino G; Traneus E; Glimelius L; Georg D; Fossati P; Carlino A; Stock M
Med Phys; 2024 Jun; 51(6):3950-3960. PubMed ID: 38696546
[TBL] [Abstract][Full Text] [Related]
40. Automated Robust Proton Planning Using Dose-Volume Histogram-Based Mimicking of the Photon Reference Dose and Reducing Organ at Risk Dose Optimization.
Kierkels RGJ; Fredriksson A; Both S; Langendijk JA; Scandurra D; Korevaar EW
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):251-258. PubMed ID: 30145392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
